Schedule 13G ownership disclosure

ONCOCYTE CORPORATION

Security class unavailable · CUSIP: 68235C107

Event date: 2019-11-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-19-018210
Form type
SC 13G
Filer
Insight Molecular Diagnostics Inc.
CIK
CIK 1642380
Filed
Nov 22, 2019
Reporting period
Nov 13, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub